Loading…
Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy
Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate cancer (PCa). The aim of this study was to compare sexual functions of PCa patients before and after intensity-modulated RT and to analyze their correlation with penile bulb (PB) doses and patient charact...
Saved in:
Published in: | Indian journal of cancer 2020-01, Vol.57 (1), p.70-75 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113 |
---|---|
cites | cdi_FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113 |
container_end_page | 75 |
container_issue | 1 |
container_start_page | 70 |
container_title | Indian journal of cancer |
container_volume | 57 |
creator | Yildirim, Halil Ergen, Sefika Sedef, Emine Sahin, Merve Karacam, Songul Senocak, Mustafa Dincbas, Fazilet |
description | Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate cancer (PCa). The aim of this study was to compare sexual functions of PCa patients before and after intensity-modulated RT and to analyze their correlation with penile bulb (PB) doses and patient characteristics.
Materials and Methods: Forty-two patients who underwent RT ± hormone therapy for PCa between 2010 and 2013 were analyzed. Sexual functions assessed by patient-reported questionnaire and physician reported scale before and 3 years after treatment. The effect of patients' age, prostate volume, testosterone levels, comorbidity, smoking status, tumor stage, RT technique, hormone therapy, and PB doses to sexual functions were investigated.
Results:After 3 years of RT, 64.3% of all patients had a lower erectile score; and 75% of patients who were previously potent (n = 24) had become impotent after treatment. However sexual desire still remained in 75.8% of patients who had desire before treatment (n = 33). Statistical analysis showed that two parameters were correlated with postradiotherapy impotency outcome; PB mean radiation dose (P = 0.033) and testosterone levels (P = 0.032).
Conclusions: RT, despite modern techniques, affects the sexual function of PCa patients in varying degrees. Reducing radiation doses to penile structures may play a role in preventing erectile dysfunction. |
doi_str_mv | 10.4103/ijc.IJC_465_18 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2370284746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A616025125</galeid><sourcerecordid>A616025125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113</originalsourceid><addsrcrecordid>eNp1kktrGzEUhUVpoG7SbdcDhe7G0WteqxBM0joEskkgO6HRXMVyNJIraTD-95Wdpm3AQYsrpO-cK-kIoa8EzznB7Nys1Xx5sxC8rgRpP6AZ6bq25E3DP6IZxqQrK9w9fkKfY1xjTBnl7QypqwAqGQvFsIt6cnnuXWFcsQk-JpmgUNIpCMVGJgMuxSIFyMtDsTVplcEELpq0K0c_TPawEeRg5MEmrSDIze4MnWhpI3z5U0_Rw_XV_eJneXv3Y7m4vC1VRSooCeW9bEiNe8V5zXrMiCZKM10r1ehuaHHPOBugantcM1pDxRnDhBDWS0ZzOUXfXnzz2X9NEJNY-ym43FJQ1mDa8ib7_qWepAVhnPYpSDWaqMRlnbvTitAqU-UR6glcvpH1DnR-srf8_AifxwCjUUcF3_8TrEDatIreTvuHi0edVU4kBtBiE8wow04QLPbBixy8-Bd8Fly8CLbeJgjx2U5bCGKE4dn57Tsq0WDx-hXYb8PktgY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2370284746</pqid></control><display><type>article</type><title>Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy</title><source>Publicly Available Content Database</source><creator>Yildirim, Halil ; Ergen, Sefika ; Sedef, Emine ; Sahin, Merve ; Karacam, Songul ; Senocak, Mustafa ; Dincbas, Fazilet</creator><creatorcontrib>Yildirim, Halil ; Ergen, Sefika ; Sedef, Emine ; Sahin, Merve ; Karacam, Songul ; Senocak, Mustafa ; Dincbas, Fazilet</creatorcontrib><description>Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate cancer (PCa). The aim of this study was to compare sexual functions of PCa patients before and after intensity-modulated RT and to analyze their correlation with penile bulb (PB) doses and patient characteristics.
Materials and Methods: Forty-two patients who underwent RT ± hormone therapy for PCa between 2010 and 2013 were analyzed. Sexual functions assessed by patient-reported questionnaire and physician reported scale before and 3 years after treatment. The effect of patients' age, prostate volume, testosterone levels, comorbidity, smoking status, tumor stage, RT technique, hormone therapy, and PB doses to sexual functions were investigated.
Results:After 3 years of RT, 64.3% of all patients had a lower erectile score; and 75% of patients who were previously potent (n = 24) had become impotent after treatment. However sexual desire still remained in 75.8% of patients who had desire before treatment (n = 33). Statistical analysis showed that two parameters were correlated with postradiotherapy impotency outcome; PB mean radiation dose (P = 0.033) and testosterone levels (P = 0.032).
Conclusions: RT, despite modern techniques, affects the sexual function of PCa patients in varying degrees. Reducing radiation doses to penile structures may play a role in preventing erectile dysfunction.</description><identifier>ISSN: 0019-509X</identifier><identifier>EISSN: 1998-4774</identifier><identifier>DOI: 10.4103/ijc.IJC_465_18</identifier><language>eng</language><publisher>Mumbai: Wolters Kluwer India Pvt. Ltd</publisher><subject>Analysis ; Cancer patients ; Cancer research ; Cancer therapies ; Cardiovascular disease ; Care and treatment ; Chronic illnesses ; Coronary vessels ; Diabetes ; Dosimetry ; Drug dosages ; Endocrine therapy ; Erectile dysfunction ; Hormones ; Hypertension ; Hypotheses ; Impotence ; Medical research ; Patients ; Physicians ; Prostate cancer ; Questionnaires ; Radiation therapy ; Radiotherapy ; Sexual disorders ; Studies ; Testosterone ; Ultrasonic imaging</subject><ispartof>Indian journal of cancer, 2020-01, Vol.57 (1), p.70-75</ispartof><rights>COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.</rights><rights>2020. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113</citedby><cites>FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2370284746?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,4024,25753,27923,27924,27925,37012,44590</link.rule.ids></links><search><creatorcontrib>Yildirim, Halil</creatorcontrib><creatorcontrib>Ergen, Sefika</creatorcontrib><creatorcontrib>Sedef, Emine</creatorcontrib><creatorcontrib>Sahin, Merve</creatorcontrib><creatorcontrib>Karacam, Songul</creatorcontrib><creatorcontrib>Senocak, Mustafa</creatorcontrib><creatorcontrib>Dincbas, Fazilet</creatorcontrib><title>Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy</title><title>Indian journal of cancer</title><description>Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate cancer (PCa). The aim of this study was to compare sexual functions of PCa patients before and after intensity-modulated RT and to analyze their correlation with penile bulb (PB) doses and patient characteristics.
Materials and Methods: Forty-two patients who underwent RT ± hormone therapy for PCa between 2010 and 2013 were analyzed. Sexual functions assessed by patient-reported questionnaire and physician reported scale before and 3 years after treatment. The effect of patients' age, prostate volume, testosterone levels, comorbidity, smoking status, tumor stage, RT technique, hormone therapy, and PB doses to sexual functions were investigated.
Results:After 3 years of RT, 64.3% of all patients had a lower erectile score; and 75% of patients who were previously potent (n = 24) had become impotent after treatment. However sexual desire still remained in 75.8% of patients who had desire before treatment (n = 33). Statistical analysis showed that two parameters were correlated with postradiotherapy impotency outcome; PB mean radiation dose (P = 0.033) and testosterone levels (P = 0.032).
Conclusions: RT, despite modern techniques, affects the sexual function of PCa patients in varying degrees. Reducing radiation doses to penile structures may play a role in preventing erectile dysfunction.</description><subject>Analysis</subject><subject>Cancer patients</subject><subject>Cancer research</subject><subject>Cancer therapies</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Chronic illnesses</subject><subject>Coronary vessels</subject><subject>Diabetes</subject><subject>Dosimetry</subject><subject>Drug dosages</subject><subject>Endocrine therapy</subject><subject>Erectile dysfunction</subject><subject>Hormones</subject><subject>Hypertension</subject><subject>Hypotheses</subject><subject>Impotence</subject><subject>Medical research</subject><subject>Patients</subject><subject>Physicians</subject><subject>Prostate cancer</subject><subject>Questionnaires</subject><subject>Radiation therapy</subject><subject>Radiotherapy</subject><subject>Sexual disorders</subject><subject>Studies</subject><subject>Testosterone</subject><subject>Ultrasonic imaging</subject><issn>0019-509X</issn><issn>1998-4774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kktrGzEUhUVpoG7SbdcDhe7G0WteqxBM0joEskkgO6HRXMVyNJIraTD-95Wdpm3AQYsrpO-cK-kIoa8EzznB7Nys1Xx5sxC8rgRpP6AZ6bq25E3DP6IZxqQrK9w9fkKfY1xjTBnl7QypqwAqGQvFsIt6cnnuXWFcsQk-JpmgUNIpCMVGJgMuxSIFyMtDsTVplcEELpq0K0c_TPawEeRg5MEmrSDIze4MnWhpI3z5U0_Rw_XV_eJneXv3Y7m4vC1VRSooCeW9bEiNe8V5zXrMiCZKM10r1ehuaHHPOBugantcM1pDxRnDhBDWS0ZzOUXfXnzz2X9NEJNY-ym43FJQ1mDa8ib7_qWepAVhnPYpSDWaqMRlnbvTitAqU-UR6glcvpH1DnR-srf8_AifxwCjUUcF3_8TrEDatIreTvuHi0edVU4kBtBiE8wow04QLPbBixy8-Bd8Fly8CLbeJgjx2U5bCGKE4dn57Tsq0WDx-hXYb8PktgY</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Yildirim, Halil</creator><creator>Ergen, Sefika</creator><creator>Sedef, Emine</creator><creator>Sahin, Merve</creator><creator>Karacam, Songul</creator><creator>Senocak, Mustafa</creator><creator>Dincbas, Fazilet</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20200101</creationdate><title>Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy</title><author>Yildirim, Halil ; Ergen, Sefika ; Sedef, Emine ; Sahin, Merve ; Karacam, Songul ; Senocak, Mustafa ; Dincbas, Fazilet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Analysis</topic><topic>Cancer patients</topic><topic>Cancer research</topic><topic>Cancer therapies</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Chronic illnesses</topic><topic>Coronary vessels</topic><topic>Diabetes</topic><topic>Dosimetry</topic><topic>Drug dosages</topic><topic>Endocrine therapy</topic><topic>Erectile dysfunction</topic><topic>Hormones</topic><topic>Hypertension</topic><topic>Hypotheses</topic><topic>Impotence</topic><topic>Medical research</topic><topic>Patients</topic><topic>Physicians</topic><topic>Prostate cancer</topic><topic>Questionnaires</topic><topic>Radiation therapy</topic><topic>Radiotherapy</topic><topic>Sexual disorders</topic><topic>Studies</topic><topic>Testosterone</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yildirim, Halil</creatorcontrib><creatorcontrib>Ergen, Sefika</creatorcontrib><creatorcontrib>Sedef, Emine</creatorcontrib><creatorcontrib>Sahin, Merve</creatorcontrib><creatorcontrib>Karacam, Songul</creatorcontrib><creatorcontrib>Senocak, Mustafa</creatorcontrib><creatorcontrib>Dincbas, Fazilet</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest_Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Indian journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yildirim, Halil</au><au>Ergen, Sefika</au><au>Sedef, Emine</au><au>Sahin, Merve</au><au>Karacam, Songul</au><au>Senocak, Mustafa</au><au>Dincbas, Fazilet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy</atitle><jtitle>Indian journal of cancer</jtitle><date>2020-01-01</date><risdate>2020</risdate><volume>57</volume><issue>1</issue><spage>70</spage><epage>75</epage><pages>70-75</pages><issn>0019-509X</issn><eissn>1998-4774</eissn><abstract>Background: Sexual dysfunction is an important side-effect after radiotherapy (RT) for prostate cancer (PCa). The aim of this study was to compare sexual functions of PCa patients before and after intensity-modulated RT and to analyze their correlation with penile bulb (PB) doses and patient characteristics.
Materials and Methods: Forty-two patients who underwent RT ± hormone therapy for PCa between 2010 and 2013 were analyzed. Sexual functions assessed by patient-reported questionnaire and physician reported scale before and 3 years after treatment. The effect of patients' age, prostate volume, testosterone levels, comorbidity, smoking status, tumor stage, RT technique, hormone therapy, and PB doses to sexual functions were investigated.
Results:After 3 years of RT, 64.3% of all patients had a lower erectile score; and 75% of patients who were previously potent (n = 24) had become impotent after treatment. However sexual desire still remained in 75.8% of patients who had desire before treatment (n = 33). Statistical analysis showed that two parameters were correlated with postradiotherapy impotency outcome; PB mean radiation dose (P = 0.033) and testosterone levels (P = 0.032).
Conclusions: RT, despite modern techniques, affects the sexual function of PCa patients in varying degrees. Reducing radiation doses to penile structures may play a role in preventing erectile dysfunction.</abstract><cop>Mumbai</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><doi>10.4103/ijc.IJC_465_18</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0019-509X |
ispartof | Indian journal of cancer, 2020-01, Vol.57 (1), p.70-75 |
issn | 0019-509X 1998-4774 |
language | eng |
recordid | cdi_proquest_journals_2370284746 |
source | Publicly Available Content Database |
subjects | Analysis Cancer patients Cancer research Cancer therapies Cardiovascular disease Care and treatment Chronic illnesses Coronary vessels Diabetes Dosimetry Drug dosages Endocrine therapy Erectile dysfunction Hormones Hypertension Hypotheses Impotence Medical research Patients Physicians Prostate cancer Questionnaires Radiation therapy Radiotherapy Sexual disorders Studies Testosterone Ultrasonic imaging |
title | Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A35%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erectile%20dysfunction%20in%20prostate%20cancer%20patients%20treated%20with%20intensity-modulated%20radiation%20therapy&rft.jtitle=Indian%20journal%20of%20cancer&rft.au=Yildirim,%20Halil&rft.date=2020-01-01&rft.volume=57&rft.issue=1&rft.spage=70&rft.epage=75&rft.pages=70-75&rft.issn=0019-509X&rft.eissn=1998-4774&rft_id=info:doi/10.4103/ijc.IJC_465_18&rft_dat=%3Cgale_proqu%3EA616025125%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c515e-124ba7160bc4463b031f1cf3f6cc7f9d80b343de58b06326e543301113ba32113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2370284746&rft_id=info:pmid/&rft_galeid=A616025125&rfr_iscdi=true |